BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8756659)

  • 1. The POU domain of SCIP/Tst-1/Oct-6 is sufficient for activation of an acetylcholine receptor promoter.
    Fyodorov D; Deneris E
    Mol Cell Biol; 1996 Sep; 16(9):5004-14. PubMed ID: 8756659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an acetylcholine receptor alpha 3 gene promoter and its activation by the POU domain factor SCIP/Tst-1.
    Yang X; McDonough J; Fyodorov D; Morris M; Wang F; Deneris ES
    J Biol Chem; 1994 Apr; 269(14):10252-64. PubMed ID: 8144606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional control of the neuronal nicotinic acetylcholine receptor gene cluster by the beta43' enhancer, Sp1, SCIP and ETS transcription factors.
    Deneris ES; Francis N; McDonough J; Fyodorov D; Miller T; Yang X
    Eur J Pharmacol; 2000 Mar; 393(1-3):69-74. PubMed ID: 10770999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell type-specific activation of neuronal nicotinic acetylcholine receptor subunit genes by Sox10.
    Liu Q; Melnikova IN; Hu M; Gardner PD
    J Neurosci; 1999 Nov; 19(22):9747-55. PubMed ID: 10559384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human involucrin promoter activity by POU domain proteins.
    Welter JF; Gali H; Crish JF; Eckert RL
    J Biol Chem; 1996 Jun; 271(25):14727-33. PubMed ID: 8663077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of gonadotropin-releasing hormone promoter activity by the POU homeodomain transcription factor SCIP/Oct-6/Tst-1: a regulatory mechanism of phenotype expression?
    Wierman ME; Xiong X; Kepa JK; Spaulding AJ; Jacobsen BM; Fang Z; Nilaver G; Ojeda SR
    Mol Cell Biol; 1997 Mar; 17(3):1652-65. PubMed ID: 9032292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of the myelin P0 gene by the POU transcription factor SCIP.
    Monuki ES; Kuhn R; Lemke G
    Mech Dev; 1993 Jul; 42(1-2):15-32. PubMed ID: 7690239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain.
    Babb R; Cleary MA; Herr W
    Mol Cell Biol; 1997 Dec; 17(12):7295-305. PubMed ID: 9372961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The J domain of papovaviral large tumor antigen is required for synergistic interaction with the POU-domain protein Tst-1/Oct6/SCIP.
    Sock E; Enderich J; Wegner M
    Mol Cell Biol; 1999 Apr; 19(4):2455-64. PubMed ID: 10082511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms for flexibility in DNA sequence recognition and VP16-induced complex formation by the Oct-1 POU domain.
    Cleary MA; Herr W
    Mol Cell Biol; 1995 Apr; 15(4):2090-100. PubMed ID: 7891704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an N-terminal transcriptional activation domain within Brn3b/POU4f2.
    Martin SE; Mu X; Klein WH
    Differentiation; 2005 Feb; 73(1):18-27. PubMed ID: 15733064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific transcriptional activation in vitro by the herpes simplex virus protein VP16.
    Arnosti DN; Preston CM; Hagmann M; Schaffner W; Hope RG; Laughlan G; Luisi BF
    Nucleic Acids Res; 1993 Dec; 21(24):5570-6. PubMed ID: 8284200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment.
    Cleary MA; Stern S; Tanaka M; Herr W
    Genes Dev; 1993 Jan; 7(1):72-83. PubMed ID: 8422989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription.
    Tanaka M; Clouston WM; Herr W
    Mol Cell Biol; 1994 Sep; 14(9):6046-55. PubMed ID: 8065338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Oct-1 POU domain stimulates adenovirus DNA replication by a direct interaction between the viral precursor terminal protein-DNA polymerase complex and the POU homeodomain.
    Coenjaerts FE; van Oosterhout JA; van der Vliet PC
    EMBO J; 1994 Nov; 13(22):5401-9. PubMed ID: 7957106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6.
    Sock E; Enderich J; Rosenfeld MG; Wegner M
    J Biol Chem; 1996 Jul; 271(29):17512-8. PubMed ID: 8663425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation.
    Qi JS; Desai-Yajnik V; Greene ME; Raaka BM; Samuels HH
    Mol Cell Biol; 1995 Mar; 15(3):1817-25. PubMed ID: 7862171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA.
    Sauter P; Matthias P
    Mol Cell Biol; 1998 Dec; 18(12):7397-409. PubMed ID: 9819426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific conformational alteration of the Oct-1 POU domain-DNA complex as the basis for differential recognition by Vmw65 (VP16).
    Walker S; Hayes S; O'Hare P
    Cell; 1994 Dec; 79(5):841-52. PubMed ID: 8001121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T antigen of human papovavirus JC stimulates transcription of the POU domain factor Tst-1/Oct6/SCIP.
    Renner K; Sock E; Gerber JK; Wegner M
    DNA Cell Biol; 1996 Dec; 15(12):1057-62. PubMed ID: 8985119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.